These effects were mainly mediated through the mTOR pathway, supporting the concept, shown in previous studies in melanoma and sarcoma cells (7, 86), that tumor PD-1: PD-L1-dependent mTOR activity drives glycolysis and proliferation in cancer cells. The gene discussed is CD274; the disease is cancer.